• About us
  • Membership
  • Contact us
  • Mon August 25, 2025

  • Home
  • Society
  • Economy
  • Politics
  • Sports
  • Culture
  • International
  • Multimedia
  • Tourism

spinal muscular atrophy

Total:2

  • Oral medicine for SMA patients delivered to Iran 2022-08-09 18:47

    Oral medicine for SMA patients delivered to Iran

    TEHRAN – The first shipment of Evrysdi, an oral medication used to treat spinal muscular atrophy (SMA), has been imported to the country, Saeed Azamian, CEO of the SMA Association of Iran, said on Tuesday.

  • FDA imports medicine for SMA patients 2022-08-02 18:57

    FDA imports medicine for SMA patients

    TEHRAN – The first batch of SPINRAZA – a drug special for patients suffering from spinal muscular atrophy (SMA) - has arrived in the country, the Food and Drug Administration director announced on Tuesday.

All Pages

Latest

  • 15130

  • Will there be another war?

  • Uprooting identity, uprooting peace: Israel’s war on the olive tree

  • Iran secures IOAA championship for second consecutive year

  • Tehran, Peking beef up sci-tech ties

  • Iran stands firm against US pressure for obedience

  • Six terrorists killed, two captured in counterterrorism operation near Pakistan border

  • Iranian innovator wins BRICS, SCO ‘Social Solution of the year’ award

  • National quantum network to be launched by March 2026

  • The Iron Dome of silence

  • Araghchi arrives in Jeddah for emergency OIC meeting 

  • Australians unite against Gaza ‘genocide’

  • Israel admits 83% of Gaza deaths are civilians  

  • Exclusive: Gaza killings mirror Israel’s decades of crimes against press, rights activist says

  • Israeli airstrikes hit civilian infrastructure in Sanaa as Yemen reiterates Gaza support

Desktop version Mobile version
Top
  • About us
  • Membership
  • Contact us
  • Home
  • Society
  • Economy
  • Politics
  • Sports
  • Culture
  • International
  • Multimedia
  • Tourism

All Content by Mehr News Agency is licensed under a Creative Commons Attribution 4.0 International License.

Developed by: Nastooh Designed by: Pixel Studio